GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $450,000 | -1.3% | 10,341 | 0.0% | 0.02% | +6.2% |
| Q4 2021 | $456,000 | +15.4% | 10,341 | 0.0% | 0.02% | +6.7% |
| Q3 2021 | $395,000 | -4.1% | 10,341 | 0.0% | 0.02% | -6.2% |
| Q2 2021 | $412,000 | +11.7% | 10,341 | 0.0% | 0.02% | +23.1% |
| Q1 2021 | $369,000 | -3.1% | 10,341 | 0.0% | 0.01% | -23.5% |
| Q4 2020 | $381,000 | -2.1% | 10,341 | 0.0% | 0.02% | +6.2% |
| Q3 2020 | $389,000 | -7.8% | 10,341 | 0.0% | 0.02% | -30.4% |
| Q2 2020 | $422,000 | +7.7% | 10,341 | 0.0% | 0.02% | -17.9% |
| Q1 2020 | $392,000 | -17.3% | 10,341 | +2.6% | 0.03% | +7.7% |
| Q4 2019 | $474,000 | +10.2% | 10,081 | 0.0% | 0.03% | +4.0% |
| Q3 2019 | $430,000 | +6.7% | 10,081 | 0.0% | 0.02% | +8.7% |
| Q2 2019 | $403,000 | -96.0% | 10,081 | +2294.5% | 0.02% | -42.5% |
| Q1 2019 | $10,081,000 | +2518.4% | 421 | -95.8% | 0.04% | +53.8% |
| Q4 2018 | $385,000 | -32.9% | 10,081 | -29.4% | 0.03% | -21.2% |
| Q3 2018 | $574,000 | -27.3% | 14,281 | -27.2% | 0.03% | -32.7% |
| Q2 2018 | $790,000 | +3.1% | 19,606 | 0.0% | 0.05% | -2.0% |
| Q1 2018 | $766,000 | -3.3% | 19,606 | -12.2% | 0.05% | -2.0% |
| Q4 2017 | $792,000 | -31.1% | 22,331 | -21.2% | 0.05% | -34.6% |
| Q3 2017 | $1,150,000 | +63.4% | 28,331 | +73.5% | 0.08% | +56.0% |
| Q2 2017 | $704,000 | +2.2% | 16,331 | 0.0% | 0.05% | +4.2% |
| Q1 2017 | $689,000 | +9.5% | 16,331 | 0.0% | 0.05% | 0.0% |
| Q4 2016 | $629,000 | -10.7% | 16,331 | 0.0% | 0.05% | -18.6% |
| Q3 2016 | $704,000 | -0.6% | 16,331 | -0.1% | 0.06% | -4.8% |
| Q2 2016 | $708,000 | +6.9% | 16,343 | +0.1% | 0.06% | +3.3% |
| Q1 2016 | $662,000 | +0.5% | 16,331 | 0.0% | 0.06% | -6.2% |
| Q4 2015 | $659,000 | +4.9% | 16,331 | 0.0% | 0.06% | -7.2% |
| Q3 2015 | $628,000 | -7.6% | 16,331 | 0.0% | 0.07% | -1.4% |
| Q2 2015 | $680,000 | -9.8% | 16,331 | 0.0% | 0.07% | -13.6% |
| Q1 2015 | $754,000 | +8.0% | 16,331 | 0.0% | 0.08% | 0.0% |
| Q4 2014 | $698,000 | +88.6% | 16,331 | +102.9% | 0.08% | +62.0% |
| Q3 2014 | $370,000 | – | 8,050 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |